Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 34Terminated 11Recruiting 8Active not recruiting 5Not yet recruiting 3Unknown 2

Sponsor Class

OTHER_GOV 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Carcinoma, Non-Small-Cell Lung 36Leukemia, Myeloid, Acute 27Colorectal Neoplasms 27Neoplasms 26Neoplasm Metastasis 22Recurrence 21Multiple Myeloma 20Advanced Solid Tumors 20Lymphoma, B-Cell 19Breast Neoplasms 18Pancreatic Neoplasms 14Lung Neoplasms 13Glioblastoma 13Carcinoma, Hepatocellular 13Lymphoma 12Brain Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Hematologic Neoplasms 11Glioma 11Squamous Cell Carcinoma of Head and Neck 10Ovarian Neoplasms 10Melanoma 10Leukemia 10Advanced Solid Tumor 10Triple Negative Breast Neoplasms 9Prostatic Neoplasms 9Head and Neck Neoplasms 9Lymphoma, Non-Hodgkin 8Esophageal Neoplasms 8Myelodysplastic Syndromes 7

Interventions

Melphalan 2Interleukin-2 2Nivolumab 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Uveal Melanoma × Clear all
NCT07501117 2026-03-30

Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma

Herlev Hospital

Phase 1 Not yet recruiting
15 enrolled
Dermatologic

Uveal Melanoma

NCT07183852 2025-09-19

GoTIL-01

Vastra Gotaland Region

Phase 1 Not yet recruiting
18 enrolled
Dermatologic

Uveal Melanoma, Melanoma

NCT05903937 2023-06-15

HAITILS-PHP

Vastra Gotaland Region

Phase 1 Not yet recruiting
6 enrolled
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡